Morgan Stanley said that stock prices have rallied since the April lows, offering a chance to rebalance portfolios. It ...

The stock attracted cornerstone investors including Hillhouse Investment, GIC and RBC Global Asset Management.

A consulting firm's report on the future of the channel reveals the ambivalence and frustration many feel about the impact of ...

While HSBC maintains a 'buy' rating for Biocon it has cut its target price to Rs 390 from the earlier Rs 400 per share.

These shares are pushing higher on Thursday. But why? The post Why Clarity Pharmaceuticals, Kelsian, Life360, and Syrah ...